What is Global Nucleic Acid Biological Reagent Market?
The Global Nucleic Acid Biological Reagent Market encompasses a wide array of biological materials and organic compounds that are pivotal in the realm of nucleic acids, which are the building blocks of life. These reagents are indispensable tools in the laboratories of life sciences, playing crucial roles in research, clinical diagnostics, and medical research. As of 2023, this market has been valued at US$ 11,240 million, showcasing the significant investment and interest in this field. The market is on a trajectory of growth, with projections indicating a value of US$ 24,200 million by 2030. This growth is expected to occur at a compound annual growth rate (CAGR) of 10.5% during the forecast period from 2024 to 2030. This surge underscores the increasing reliance on and demand for nucleic acid-based applications in scientific research and healthcare, highlighting the market's vital role in advancing our understanding and treatment of various diseases.
Customized Synthetic Nucleic Acid, Cloning Carrier in the Global Nucleic Acid Biological Reagent Market:
English: #GlobalNucleicAcidMarket #BiologicalReagents #LifeScienceResearch #ClinicalDiagnostics #MedicalResearch #MarketGrowth #CAGR #HealthcareInnovation #DiseaseTreatment #ScienceAdvancement
College, Pharmaceutical Company, Others in the Global Nucleic Acid Biological Reagent Market:
Japanese: #グローバル核酸市場 #生物試薬 #ライフサイエンス研究 #臨床診断 #医学研究 #市場成長 #CAGR #ヘルスケアイノベーション #病気治療 #科学進歩
Global Nucleic Acid Biological Reagent Market Outlook:
Korean: #글로벌핵산시장 #생물학적시약 #생명과학연구 #임상진단 #의학연구 #시장성장 #CAGR #헬스케어혁신 #질병치료 #과학진보
| Report Metric | Details |
| Report Name | Nucleic Acid Biological Reagent Market |
| Accounted market size in 2023 | US$ 11240 million |
| Forecasted market size in 2030 | US$ 24200 million |
| CAGR | 10.5% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Thermo Fisher, Qiagen, Takara, Bio-Rad, CWBIO, Abclonal Technology, Yeasen Biotechnology, PerkinElmer, Genscript, Novoprotein, Vazyme, TransGen Biotech |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
